These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21647568)

  • 1. Tissue-type plasminogen activator-assisted drainage of suprachoroidal hemorrhage showing a kissing configuration.
    Murata T; Kikushima W; Imai A; Toriyama Y; Tokimitsu M; Kurokawa T
    Jpn J Ophthalmol; 2011 Jul; 55(4):431-432. PubMed ID: 21647568
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of experimental suprachoroidal hemorrhage with intravenous tissue plasminogen activator.
    Liu JC; Peyman GA; Oncel M
    Int Ophthalmol; 1990 Jul; 14(4):267-70. PubMed ID: 2115030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suprachoroidal haemorrhage (SCH) drainage using suprachoroidal tissue plasminogen activator (t-PA) after complicated cataract extraction (two-staged procedure): early intervention could mean better vision.
    Akram H; Dowlut MS; Chandra A
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33958363
    [No Abstract]   [Full Text] [Related]  

  • 4. Extensive dural sinus thrombosis: successful recanalization with thrombolysis and a novel thrombectomy device.
    Blackham KA
    J Neurosurg; 2011 Jan; 114(1):133-5. PubMed ID: 20205511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental suprachoroidal hemorrhage with subconjunctival injection of tissue plasminogen activator: a negative report.
    Liu JC; Peyman GA; Oncel M
    Ophthalmic Surg; 1990 Sep; 21(9):641-3. PubMed ID: 2123529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choroidal hemorrhage associated with systemic tissue plasminogen activator.
    Khawly JA; Ferrone PJ; Holck DE
    Am J Ophthalmol; 1996 May; 121(5):577-8. PubMed ID: 8610807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of stroke therapy must not be mired by past arguments.
    Buchan AM; Karbalai HG; Sutherland BA
    Lancet; 2015 Aug; 386(9994):654. PubMed ID: 26334159
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage.
    Kinouchi H; Ogasawara K; Shimizu H; Mizoi K; Yoshimoto T
    Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing Delayed Suprachoroidal Hemorrhage After Insertion of XEN45 Glaucoma Device.
    Stringa F; Ali Z; Christou S; Karandikar S; Shankar V
    J Glaucoma; 2019 May; 28(5):e72-e74. PubMed ID: 30585940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator in the percutaneous drainage of splenic abscess.
    Statler JD; Doherty RD; McLaughlin JJ; Gleason JD; McDermott MP
    J Vasc Interv Radiol; 2010 Feb; 21(2):307-9. PubMed ID: 20036149
    [No Abstract]   [Full Text] [Related]  

  • 11. Retinal and Choroidal Haemorrhage after Tissue Plasminogen Activator Administration.
    Lee S; Gjerde H; Gubitz G
    Can J Neurol Sci; 2017 Jul; 44(4):461-462. PubMed ID: 28294935
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of suprachoroidal hemorrhage with tissue plasminogen activator.
    Kwon OW; Kang SJ; Lee JB; Lee SC; Yoon YD; Oh JH
    Ophthalmologica; 1998; 212(2):120-5. PubMed ID: 9486552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke salvage using a suction thrombectomy device and tissue plasminogen activator.
    Thompson C; Murphy T; Hampson C
    Med Health R I; 2012 Feb; 95(2):59-61. PubMed ID: 22474879
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.
    Papavasileiou E; Steel DH; Liazos E; McHugh D; Jackson TL
    Retina; 2013 Apr; 33(4):846-53. PubMed ID: 23400079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subretinal tissue plasminogen-assisted vitrectomy for posttraumatic full-thickness macular hole with submacular hemorrhage.
    Kumar P; Kumar V; Ravani R; Agarwal S
    Indian J Ophthalmol; 2018 Mar; 66(3):474-476. PubMed ID: 29480275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of submacular hemorrhage combined with tissue plasminogen activator (a case report)].
    Korda V; Dúbravská Z; Hejcmanová D; Rozsíval P
    Cesk Slov Oftalmol; 2006 Jul; 62(4):275-9. PubMed ID: 16895061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive suprachoroidal hemorrhage: secondary treatment and outcome.
    Meier P; Wiedemann P
    Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):28-32. PubMed ID: 10664049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragmentation of an intracerebral embolus after IV tissue plasminogen activator treatment.
    Artinian M; Babikian V
    AJR Am J Roentgenol; 2001 Jun; 176(6):1603. PubMed ID: 11373248
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of intravenous recombinant tissue plasminogen activator in recent trauma.
    Mahuwala Z; Hinduja A
    Acta Neurol Belg; 2014 Jun; 114(2):163-4. PubMed ID: 24190278
    [No Abstract]   [Full Text] [Related]  

  • 20. Pneumatic displacement of acute submacular hemorrhage with and without the use of tPA.
    Georgalas I; Papaconstantinou D; Karagiannis D; Ladas I
    Eur J Ophthalmol; 2011; 21(2):220; author reply 221. PubMed ID: 20853260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.